ABVC BioPharma, Inc. (ABVC) Gross profit 2016–2025
ABVC BioPharma, Inc. (ABVC) annual gross profit history from SEC filings — each fiscal year as reported.
$508,826FY2025 · since FY2016: $2,839 → $508,826
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $508,826 | +440.1% |
| FY2024 | -$149,607 | -121.9% |
| FY2023 | $683,368 | +94.9% |
| FY2022 | $350,711 | -24.5% |
| FY2021 | $464,329 | -31.9% |
| FY2020 | $681,582 | +482.2% |
| FY2019 | -$178,324 | — |
| FY2017 | -$32 | -101.1% |
| FY2016 | $2,839 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net incomeABVC Net marginABVC Gross marginABVC Operating incomeABVC Operating marginABVC Operating cash flowABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →